Epidermal growth factor induces human oviductal epithelial cell invasion by down-regulating E-cadherin expression

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 8, 2012, Pages

  Cheng, Jung Chien ^a   Chang, Hsun Ming ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIGEL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OVIDUCT; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

CADHERINS; CELLS, CULTURED; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FALLOPIAN TUBES; FEMALE; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAIRED BOX TRANSCRIPTION FACTORS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTORS;

GASTROPODA;

EID: 84864815678     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2751     Document Type: Article

References (57)

1. Landen Jr NC, Birrer MJ, Sood AK 2008 Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 26:995-1005 (Pubitemid 351398093)
2. Shih IeM, Kurman RJ 2004 Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511-1518 (Pubitemid 38529752)
3. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC 2001 Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22:255-288 (Pubitemid 32458162)
4. Scully RE 1995 Pathology of ovarian cancer precursors. J Cell Biochem Suppl 23:208-218 (Pubitemid 26032877)
5. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP 2008 Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53:127-138 (Pubitemid 352032762)
6. Dubeau L 2008 The cell of origin of ovarian epithelial tumours. Lancet Oncol 9:1191-1197
7. Cavallaro U, Christofori G 2004 Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118-132 (Pubitemid 38198740)
8. Peæina-Slaus N 2003 Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 3:17
9. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W 1991 E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185 (Pubitemid 21909684)
10. Thiery JP, Acloque H, Huang RY, Nieto MA 2009 Epithelial-mesenchymal transitions in development and disease. Cell 139:871-890
11. Kuwabara Y, Yamada T, Yamazaki K, Du WL, Banno K, Aoki D, Sakamoto M 2008 Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis. Cancer Sci 99:1933-1939
12. Huber MA, Kraut N, Beug H 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558 (Pubitemid 41267170)
13. Citri A, Yarden Y 2006 EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7:505-516 (Pubitemid 44036456)
14. Bartlett JM, Langdon SP, Simpson BJ, Stewart M, Katsaros D, Sismondi P, Love S, Scott WN, Williams AR, Lessells AM, Macleod KG, Smyth JF, Miller WR 1996 The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer 73:301-306 (Pubitemid 26047507)
15. Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brännström M, Janson PO, Enerback S, Hedin L 1997 E-Cadherin expression in human epithelial ovarian cancer and normal ovary. Int J Cancer 74:275-280 (Pubitemid 27321795)
16. Zhu Y, Nilsson M, Sundfeldt K 2010 Phenotypic plasticity of the ovarian surface epithelium: TGF-β 1 induction of epithelial to mesenchymal transition(EMT)in vitro. Endocrinology 151:5497-5505
17. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N 2006 Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 290:C1532-C1542 (Pubitemid 43830793)
18. Salamanca CM, Maines-Bandiera SL, Leung PC, Hu YL, Auersperg N 2004 Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium. J Soc Gynecol Investig 11:241-251 (Pubitemid 38561370)
19. Cheng JC, Klausen C, Leung PC 2010 Hydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells. Mol Endocrinol 24:1569-1580
20. Lei ZM, Rao CV 1992 Expression of epidermal growth factor (EGF) receptor and its ligands, EGF and transforming growth factor-α, in human fallopian tubes. Endocrinology 131:947-957
21. Chegini N, Zhao Y, McLean FW 1994 Expression of messenger ribonucleic acid and presence of immunoreactive proteins for epidermal growth factor (EGF), transforming growth factor α (TGF α) and EGF/TGF α receptors and 125I-EGF binding sites in human fallopian tube. Biol Reprod 50:1049-1058 (Pubitemid 24116039)
22. Auersperg N 2011 The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30:12-21
23. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH, Kindelberger DW, Hirsch MS, Crum CP, Marto JA, Drapkin R 2010 Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 29:1103-1113
24. Lee YL, Lee KF, Xu JS, Wang YL, Tsao SW, Yeung WS 2001 Establishment and characterization of an immortalized human oviductal cell line. Mol Reprod Dev 59:400-409 (Pubitemid 32601845)
25. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25:402-408 (Pubitemid 34164012)
26. Woo MM, Salamanca CM, Minor A, Auersperg N 2007 An improved assay to quantitate the invasiveness of cells in modified Boyden chambers. In Vitro Cell Dev Biol Anim 43:7-9 (Pubitemid 47087329)
27. Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF 2007 Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 104:331-337 (Pubitemid 46135661)
28. Poon SL, Hammond GT, Leung PC 2009 Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion. Mol Endocrinol 23:1646-1656
29. Xu F, Yu Y, Le XF, Boyer C, Mills GB, Bast Jr RC 1999 The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expression. Clin Cancer Res 5:3653-3660
30. Bain J, McLauchlan H, Elliott M, Cohen P 2003 The specificities of protein kinase inhibitors: an update. Biochem J 371:199-204 (Pubitemid 36458094)
31. Davies SP, Reddy H, Caivano M, Cohen P 2000 Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105
32. Peinado H, Olmeda D, Cano A 2007 Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428 (Pubitemid 46809165)
33. Carpenter G 1987 Receptors for epidermal growth factor and other polypeptide mitogens. Annu Rev Biochem 56:881-914
34. Wang D, Su L, Huang D, Zhang H, Shin DM, Chen ZG 2011 Downregulation of E-cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. Mol Cancer 10:116
35. Bongso A, Ng SC, Fong CY, Ratnam S 1991 Improved fertilization rates of human oocytes in coculture. J In Vitro Fert Embryo Transf 8:216-221
36. Kervancioglu ME, Saridogan E, Atasü T, Camlibel T, Demircan A, Sarikamis B, Djahanbakhch O 1997 Human fallopian tube epithelial cell co-culture increases fertilization rates in male factor infertility but not in tubal or unexplained infertility. Hum Reprod 12:1253-1258 (Pubitemid 27273555)
37. Kurachi H, Morishige K, Imai T, Homma H, Masumoto N, Yoshimoto Y, Miyake A 1994 Expression of epidermal growth factor and transforming growth factor-α in fallopian tube epithelium and their role in embryogenesis. Horm Res 41(Suppl 1):48-54 (Pubitemid 24169638)
38. Barr S, Thomson S, Buck E, Russo S, Petti F, Sujka-Kwok I, Eyzaguirre A, Rosenfeld-Franklin M, Gibson NW, Miglarese M, Epstein D, Iwata KK, Haley JD 2008 Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal- like transitions. Clin Exp Metastasis 25:685-693
39. Palayekar MJ, Herzog TJ 2008 The emerging role of epidermal growth factor receptor inhibitors in ovarian cancer. Int J Gynecol Cancer 18:879-890
40. Karst AM, Drapkin R 2010 Ovarian cancer pathogenesis: a model in evolution. J Oncol 2010:932371
41. Crum CP 2009 Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 3:165-170
42. Karst AM, Levanon K, Drapkin R 2011 Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci USA 108:7547-7552
43. Arias EB, Verhage HG, Jaffe RC 1994 Complementary deoxyribonucleic acid cloning and molecular characterization of an estrogendependent human oviductal glycoprotein. Biol Reprod 51:685-694 (Pubitemid 24284401)
44. Rapisarda JJ, Mavrogianis PA, O'Day-Bowman MB, Fazleabas AT, Verhage HG 1993 Immunological characterization and immunocytochemical localization of an oviduct-specific glycoprotein in the human. J Clin Endocrinol Metab 76:1483-1488 (Pubitemid 23164365)
45. Woo MM, Gilks CB, Verhage HG, Longacre TA, Leung PC, Auersperg N 2004 Oviductal glycoprotein, a new differentiation-based indicator present in early ovarian epithelial neoplasia and cortical inclusion cysts. Gynecol Oncol 93:315-319 (Pubitemid 38507595)
46. Akerman GS, Tolleson WH, Brown KL, Zyzak LL, Mourateva E, Engin TS, Basaraba A, Coker AL, Creek KE, Pirisi L 2001 Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes. Cancer Res 61:3837-3843 (Pubitemid 32695001)
47. Henic E, Sixt M, Hansson S, Høyer-Hansen G, Casslén B 2006 EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor. Gynecol Oncol 101:28-39
48. Feldkämper M, Enderle-Schmitt U, Hackenberg R, Schulz KD 1994 Urinary excretion of growth factors in patients with ovarian cancer. Eur J Cancer 30A:1851-1858 (Pubitemid 24377163)
49. Baron AT, Lafky JM, Boardman CH, Balasubramaniam S, Suman VJ, Podratz KC, Maihle NJ 1999 Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 8:129-137 (Pubitemid 29085379)
50. Cheng JC, Auersperg N, Leung PC 2011 Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin. Oncogene 30:1020- 1031
51. Xu Z, Jiang Y, Steed H, Davidge S, Fu Y 2010 TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells. Biochem Biophys Res Commun 401:376-381
52. Lee MY, Chou CY, Tang MJ, Shen MR 2008 Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14:4743-4750
53. Grotegut S, von Schweinitz D, Christofori G, Lehembre F 2006 Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25:3534-3545 (Pubitemid 44264864)
54. Sabbah M, Emami S, Redeuilh G, Julien S, Prévost G, Zimber A, Ouelaa R, Bracke M, De Wever O, Gespach C 2008 Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers. Drug Resist Updat 11:123-151
55. Thiery JP 2002 Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442-454
56. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y, Abbruzzese JL, Hortobagyi GN, Hung MC 2007 Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67:9066-9076 (Pubitemid 47535891)
57. Uttamsingh S, Bao X, Nguyen KT, Bhanot M, Gong J, Chan JL, Liu F, Chu TT, Wang LH 2008 Synergistic effect between EGF and TGF-β1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27:2626-2634 (Pubitemid 351550880)